While ABVD is a standard treatment for Hodgkin Lymphoma, there are alternative treatments available, including other chemotherapy regimens like BEACOPP and Stanford V, and targeted therapies such as brentuximab vedotin. The choice of treatment is typically determined by the oncologist based on the specific characteristics of the cancer and the patient’s overall health.
